Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20385841 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Progression Rate of MSA Under EGCG Supplementation as Anti-Aggregation-Approach
Condition: Multiple System Atrophy
Interventions: Drug: EGCG as putative neuroprotective agent;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.